JP2018518511A5 - - Google Patents

Download PDF

Info

Publication number
JP2018518511A5
JP2018518511A5 JP2017566839A JP2017566839A JP2018518511A5 JP 2018518511 A5 JP2018518511 A5 JP 2018518511A5 JP 2017566839 A JP2017566839 A JP 2017566839A JP 2017566839 A JP2017566839 A JP 2017566839A JP 2018518511 A5 JP2018518511 A5 JP 2018518511A5
Authority
JP
Japan
Prior art keywords
composition
subject
administration
immune
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017566839A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018518511A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/064613 external-priority patent/WO2016207314A2/en
Publication of JP2018518511A publication Critical patent/JP2018518511A/ja
Publication of JP2018518511A5 publication Critical patent/JP2018518511A5/ja
Pending legal-status Critical Current

Links

JP2017566839A 2015-06-26 2016-06-23 細胞質dna監視分子の調節方法 Pending JP2018518511A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562185230P 2015-06-26 2015-06-26
US62/185,230 2015-06-26
PCT/EP2016/064613 WO2016207314A2 (en) 2015-06-26 2016-06-23 Methods of modulating cytosolic dna surveillance molecules

Publications (2)

Publication Number Publication Date
JP2018518511A JP2018518511A (ja) 2018-07-12
JP2018518511A5 true JP2018518511A5 (enExample) 2019-07-18

Family

ID=56235815

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017566839A Pending JP2018518511A (ja) 2015-06-26 2016-06-23 細胞質dna監視分子の調節方法

Country Status (22)

Country Link
US (1) US20190233825A1 (enExample)
EP (1) EP3313376A2 (enExample)
JP (1) JP2018518511A (enExample)
KR (1) KR20180021874A (enExample)
CN (1) CN108472255A (enExample)
AR (1) AR105160A1 (enExample)
AU (1) AU2016282879A1 (enExample)
BR (1) BR112017028121A2 (enExample)
CA (1) CA2990526A1 (enExample)
CL (1) CL2017003373A1 (enExample)
CR (1) CR20180003A (enExample)
DO (1) DOP2017000313A (enExample)
HK (1) HK1256128A1 (enExample)
IL (1) IL256264A (enExample)
MX (1) MX2017017141A (enExample)
PE (1) PE20181208A1 (enExample)
PH (1) PH12017502413A1 (enExample)
RU (1) RU2018102915A (enExample)
SG (1) SG10201913395VA (enExample)
TW (1) TW201710509A (enExample)
UY (1) UY36756A (enExample)
WO (1) WO2016207314A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3220895B1 (en) 2014-11-21 2022-08-31 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
PE20190566A1 (es) 2016-07-26 2019-04-22 Bayer Animal Health Gmbh Aumento de la fertilidad en especies bovinas
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US155950A (en) * 1874-10-13 Improvement in hand-saws
JP3468773B2 (ja) * 1994-07-15 2003-11-17 ザ ユニバーシティ オブ アイオワ リサーチ ファウンデーション 免疫調節オリゴヌクレオチド
US6339068B1 (en) * 1997-05-20 2002-01-15 University Of Iowa Research Foundation Vectors and methods for immunization or therapeutic protocols
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
ATE428790T1 (de) * 2000-09-25 2009-05-15 Genetronics Inc Verbessertes system zur regulation der transgenexpression
AU2002953015A0 (en) * 2002-12-02 2002-12-12 Women's And Children's Hospital Modified lacz gene
WO2005033265A2 (en) * 2003-04-25 2005-04-14 Epimmune Inc. Optimized multi-epitope constructs and uses thereof
MY146351A (en) * 2003-05-29 2012-08-15 Schering Plough Ltd Compositions for treating infection in cattle and swine
AU2005271247A1 (en) * 2004-08-13 2006-02-16 The Trustees Of The University Of Pennsylvania Antibiotic resistance free DNA vaccines
WO2006017856A2 (en) * 2004-08-13 2006-02-16 The Trustees Of The University Of Pennsylvania Methods for constructing antibiotic resistance free vaccines
DK2429581T3 (en) * 2009-05-14 2015-11-09 Bayer Ip Gmbh Improved immune responses in birds
PT2654785T (pt) * 2010-12-22 2019-06-25 Bayer Ip Gmbh Resposta imunitária melhorada em espécies bovinas
BR112013029968A2 (pt) * 2011-05-26 2017-01-31 Intervet Int Bv oligodesoxinucleotídeo imunoestimulatório não metilado, vetor, vacina para prevenir ou combater uma doença infecciosa, e, método para a detecção de oligodesoxinucleotídeos imunoestimulatórios
AR091569A1 (es) * 2012-06-28 2015-02-11 Intervet Int Bv Receptores de tipo toll
MX2016010993A (es) * 2014-02-28 2017-05-01 Bayer Animal Health Gmbh Plasmidos inmunoestimuladores.

Similar Documents

Publication Publication Date Title
US12161711B2 (en) Lassa virus vaccine
US20220347100A1 (en) LIPID NANOPARTICLES FOR DELIVERING mRNA VACCINES
JP7523897B2 (ja) 呼吸器合胞体ウイルス(rsv)ワクチン
JP2017512202A5 (enExample)
US20210401971A1 (en) Mers coronavirus vaccine
JP4782675B2 (ja) ワクチン接種用スフィンゴイドポリアルキルアミン抱合体
RU2013133730A (ru) Повышение иммунного отклика у видов крупного рогатого скота
JP4294584B2 (ja) 核酸ワクチン接種の免疫応答を高めるための方法
RU2016138321A (ru) Иммуностимулирующие плазмиды
KR20220144416A (ko) 코로나바이러스 백신
JP2018518511A5 (enExample)
WO2021236980A1 (en) Coronavirus antigen compositions and their uses
US12331078B2 (en) Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same
CN116406299A (zh) 用于递送mRNA疫苗的脂质纳米颗粒
US20230136960A1 (en) Novel MRNA-Based COVID-19 Multi-Valent Vaccine and Methods of Scaled Production of the Same
TW201427686A (zh) 改良之疫苗組成物及使用方法
EP3528827A1 (en) Influenza hemagglutinin protein vaccines
RU2018102915A (ru) Способы модуляции контрольных молекул цитозольной днк
Jazi et al. In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine
AU2017386682A1 (en) Influenza vaccines
US20220175909A1 (en) Influenza vaccine composition based on novel nucleic acid
JP2023550667A (ja) 免疫刺激性組成物
AR105568A1 (es) Un método para provocar una respuesta inmunitaria en un sujeto receptor de especie porcina
WO2023218420A1 (en) Mrna compositions for inducing latent hiv-1 reversal
CN100469393C (zh) 用于接种的sphingoid聚烷基胺缀合物